A surprising finding from our sequencing of Eμ-Myc lymphomas was the identification of additional putative oncogenic lesions in the context of Cdkn2a loss, namely for lymphomas #4242 (Bcor frameshift deletion), ML353 (KrasQ61H) and #6066 (NrasQ61K). This evidence concerns the gene CDKN2A and lymphoma.